Latest news
Search articles
Genomic testing can end diagnostic odysseys for patients with complex neurological and neurodegenerative diseases
February 23, 2021
A Melbourne Genomics study published in the Journal of Neurological Sciences found that genomic testing is a valuable diagnostic tool for a range of complex neurological diseases.
New bioinformatics software helps create new testing pipelines faster
February 23, 2021
Melbourne Genomics Health Alliance-developed bioinformatics application, aCLImatise, significantly reduces workforce effort required to build a clinical testing pipeline, enabling laboratories to implement new bioinformatic innovations faster.
Genomic testing for infants born with isolated hearing loss is cost-effective
February 23, 2021
A first-of-its-kind study, auspiced by Melbourne Genomics Health Alliance and published in The Laryngoscope, found genomic sequencing for babies born with isolated hearing loss to be cost-effective.
Immersion learning drives wider adoption of genomic medicine
December 14, 2020
Immersion learning not only improves the skills and knowledge of individual clinicians but drives new linkages between medical specialties and genetics services that can improve patient care, according to new Melbourne Genomics research findings.
First-of-its-kind chatbot developed to support genetic counselling
December 1, 2020
Scientists at CSIRO, Australia’s national science agency, in partnership with Melbourne Genomics Health Alliance, have developed an Australian-first digital conversation agent (a ‘chatbot’) that could support patients in making informed decisions about genomic testing for future health risks.
- 1 of 24
- Next ›